Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide-Reference-Cited by-同舟云学术

Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide

Published:2010-12 Issue:2 Volume:298 Page:250-257
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lu Shan,Tan Zongqin,Wortman Matthew,Lu Shan,Dong Zhongyun

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Cancer statistics, 2005;Jemal;CA Cancer J. Clin.,2005

2. Challenges in the management of prostate cancer;Crawford;Br. J. Urol.,1992

3. Molecular basis for the antiandrogen withdrawal syndrome;Miyamoto;J. Cell. Biochem.,2004

4. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins;Aziz;Mol. Cancer Ther.,2006

5. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells;Yuan;Carcinogenesis,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers;Cancer Research Communications;2023-11-20

2. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output;Cancers;2020-12-07

3. Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer;BMC Cancer;2018-12

4. Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth;Molecular Cancer Therapeutics;2012-04-10